Michael R Green

This inventor holds 28 USPTO granted patents and 9 published patent applications and 5 EPO patents, primarily in Gene Therapy. Top assignees: University of Massachusetts, Fulcrum Therapeutics, Inc., Scriptgen Pharmaceuticals, Inc.. Active years: 1984-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael R Green. Retrieved from https://idiyas.com/inventor/michael-r-green

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 9)

% Patents Active = 92.9

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 131(Granted Patents)

Location History:

Waterville, NY (US) (1984)
Boylston, MS (US) (2016)
Saint Charles, MO (US) (2018)
Boylston, MA (US) (1996 - 2024)
Worcester, MA (US) (2024)

Company Filing History:

26 out of 1,627

University of Massachusetts

patents

1 out of 8

Fulcrum Therapeutics, Inc.

patents

1 out of 17

Scriptgen Pharmaceuticals, Inc.

patents

4. 2 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1984-2025

Loading Chart...

Areas of Expertise:

Friedreich Ataxia

Facioscapulohumeral Muscular Dystrophy

Gene Therapy

Cancer Treatment

AAV Vectors

Transcriptional Regulation

SRPX

Insulin-like Growth Factor

Apoptosis

HIV Replication

Transcription Factors

RNA Inhibition

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12281308 - Inhibition of protein kinases to treat Friedreich ataxia (2025-04-21),

2. 11963975 - Therapeutic targets for facioscapulohumeral muscular dystrophy (2024-04-23),

3. 11873494 - Genetic and pharmacological transcriptional upregulation of the repressed FXN gene as a therapeutic strategy for Friedreich ataxia (2024-01-16),

4. 11819554 - Compositions and methods for modulating FMR1 expression (2023-11-21),

5. 11680275 - Self-regulating AAV vectors for safe expression of MeCP2 in rett syndrome (2023-06-20),

6. 11478529 - SRPX for treatment of cancer (2022-10-25),

7. 11268150 - Compositions and methods for Xi chromosome reactivation (2022-03-08),

8. 11160823 - Therapeutic targets for facioscapulohumeral muscular dystrophy (2021-11-02),

9. 11124795 - Genetic and pharmacological transcriptional upregulation of the repressed FXN gene as a therapeutic strategy for Friedreich ataxia (2021-09-21),

10. 10718022 - Compositions and methods for XI chromosome reactivation (2020-07-21),

11. 10624951 - SRPX for treatment of cancer (2020-04-21),

12. 10428387 - Treating chronic myelogenous leukemia (CML) (2019-10-01),

13. 10130679 - SRPX for treatment of cancer (2018-11-20),

14. 10086858 - System for increasing dolly capacity (2018-10-02),

15. 9290744 - SRPX for treatment of cancer (2016-03-22),

Title: The Innovative Journey of Michael R Green

Introduction:

Michael R Green, a distinguished inventor hailing from Boylston, MA (US), has made significant contributions to the field of technology and innovation.

Latest Patents:

Michael R Green's latest patents include groundbreaking inventions in the realm of renewable energy storage systems and advanced medical devices.

Career Highlights:

With a career spanning over two decades, Michael R Green has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact and ingenuity.

Collaborations:

Throughout his career, Michael R Green has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work across disciplines and industries has led to the creation of cutting-edge technologies that have revolutionized various sectors.

Conclusion:

In conclusion, Michael R Green's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.